
If you are comparing weight loss options in Marietta, you will run into two versions of the same molecule at very different prices. Here is what actually separates them, written plainly, because the marketing on both sides tends to obscure it.
Medically reviewed by Kent Cohen, MD, FACEP — Medical Director, Balanced Bodies: Longevity + Wellness Clinic. Last reviewed October 2026.
They contain the same active ingredient
Ozempic and Wegovy are brand-name products made by Novo Nordisk. Both contain semaglutide. Ozempic is approved for type 2 diabetes, Wegovy for weight management, and they differ in dosing rather than in molecule.
Compounded semaglutide is prepared by a compounding pharmacy. The active ingredient is semaglutide in both cases.
What is genuinely different
Approval status. This is the central difference and it is not a technicality. Brand-name products went through FDA review and were approved. Compounded preparations are not FDA-approved finished products. The FDA has not reviewed them for safety or effectiveness, and the agency does not verify the potency or purity of an individual compounded batch.
Who makes it. Brand products come from one manufacturer under one standard. Compounded preparations come from compounding pharmacies, which are licensed and inspected but operate under a different framework. Which pharmacy your clinic uses genuinely matters. We source through licensed 503A pharmacies.
Formulation. Some compounded preparations include additional ingredients, such as B12 or other additives. That is a real difference from the brand product and worth asking about.
Price. The reason most people are reading this. Brand-name semaglutide without insurance coverage frequently runs well over a thousand dollars a month. Our compounded semaglutide is $199 a month, including provider visits, labs and InBody scans.
What to be sceptical of
Be wary of any clinic that describes compounded semaglutide as a “generic” version of Ozempic. It is not. A generic is an approved copy that has demonstrated equivalence to the original. No generic semaglutide exists in the United States.
Be equally wary of anyone selling semaglutide in forms the brand does not exist in, or at prices far below everyone else, or without a provider consultation. Semaglutide “sold for research purposes only” is not a medication and is not intended for human use.
The regulatory picture is moving
Compounding of GLP-1 medications has been through significant regulatory change, and the rules continue to evolve. A clinic should be able to tell you which pharmacy supplies its medication and on what basis it is compounded. If you cannot get a straight answer to that question, that tells you something.
How we handle it
We tell patients plainly that what we dispense is compounded, that it is not FDA-approved, and that it is not the brand-name product. That disclosure appears on every page where we mention these medications, because you should be deciding with the facts in front of you.
Our pricing is published: semaglutide at $199 a month and tirzepatide at $249, each including medication, provider visits, lab work and monthly InBody body composition scans. Consultations are free.
If you are weighing the two molecules rather than the two sources, our comparison of semaglutide vs tirzepatide covers that.
Further reading
Compounded medications are not FDA-approved finished products and are not the brand-name versions. Results vary between patients.
